Earnings History Data for Genprex, Inc. (GNPX) - NYSE NASDAQ
To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.
For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.
For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.
See the full list of available companies here.
Genprex, Inc.
Genprex Inc. operates as a biotechnology company. It discovers and develops immunogene therapies for cancer treatment as well as clinical research, gene therapies, consulting and other related medical services. The company's initial product candidate is Oncoprex(TM) immunogene therapy which treats non-small cell lung cancer. Genprex Inc. is based in United States.
| Release Date | Time | Est. Time | Symbol | Name | Market Cap (M) | Rep. EPS | Est. EPS | Last years EPS | SeekingAlpha Headline | Price | Change | Ext. Hours Price | Ext. Hours Change | 52 Week Range | Volume | Avg. Volume | Ext. Hours Volume | Top Mover |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 09-08-2024 | AH | GNPX | GENPREX | 3.00 | -3.00 | -2.30 | 0.00 | 1.26 | -0.16 (-11.26%) |
1.53 | 0.11 (7.75%) |
1.22 - 25.58 | 45,008 | 20,000 | 529 | |||
|
|
||||||||||||||||||
| 15-05-2024 | AH | GNPX | GENPREX | 5.00 | -3.69 | -2.54 | 0.00 | 2.46 | -0.05 (-2.00%) |
0.0 | 0.0 (0.00%) |
2.09 - 42.40 | 42,992 | 50,000 | 0 | |||
|
|
||||||||||||||||||